ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
2020 ESMO Updates on Advanced NSCLC: Adjuvant Osimertinib for EGFRm Disease, Pembro for PD-L1+ Disease, Lorlatinib for 1L ALK+ Disease, Cemiplimab, Sotorasib in Heavily Pre-Treated Disease
By
ecancer
FEATURING
Bishal Gyawali
By
ecancer
FEATURING
Bishal Gyawali
Login to view comments.
Click here to Login
